最後更新 2024-11-21 16:27:10 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

3.9%


截至2024-09-30

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

艾克維亞控股公司(IQVIA Holdings Inc.)為生命科學行業提供先進的分析、技術解決方案和臨床研究服務,業務範圍涵蓋美洲、歐洲、非洲和亞太地區。該公司由三個業務部門組成:技術與分析解決方案、研發解決方案,以及合同銷售與醫療解決方案。

技術與分析解決方案部門提供一系列基於雲端的應用程式和相關實施服務;提供現實世界解決方案,使生命科學和醫療服務客戶能夠產生和傳播證據,從而為醫療決策提供依據,並改善患者的治療效果;以及戰略和實施諮詢服務,如先進分析和商業流程外包服務。該部門還提供與藥品銷售、處方趨勢、醫療治療和各種渠道(包括零售、醫院和郵購)的促銷活動相關的國家級績效指標,以及對區域、郵遞區號和個別開具處方者的銷售或處方活動的測量。

研發解決方案部門提供項目管理和臨床監測;臨床試驗支持;虛擬試驗;以及戰略規劃和設計服務,同時還提供中央實驗室、基因組、生物分析、ADME、發現以及疫苗和生物標記實驗室服務。

合同銷售與醫療解決方案部門提供醫療服務提供者和患者參與服務,以及科學戰略和醫療事務服務。該公司的客戶包括製藥、生物技術、醫療器械和診斷以及消費者健康公司。該公司與HealthCore, Inc.有戰略合作關係。該公司原名為Quintiles IMS Holdings, Inc.,於2017年11月更名為IQVIA Holdings Inc。該公司成立於1982年,總部位於北卡羅來納州達勒姆。



IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Diagnostics & Research

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning